CLINICAL_TRIALS
trial_result
· 2017-03-22
Clinical Trial Update: Pediatric Schizophrenia Efficacy and Safety Study [Phase 3]
Summary
Phase 3 pediatric schizophrenia efficacy and safety trial completed; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2017-03-22